Search Results 3031-3040 of 17388 for colitis

  1. Relapse Prediction Following Discontinuation of Tocilizumab In Giant Cell Arteritis - Mayo Clinic

    In addition, this study will leverage the use of wearable technology (Oura ring) and machine learning to detect physiologic changes that can forecast flare in ...

  2. Patient Stories - Teerin Liewluck, M.D. - Mayo Clinic

    Fuel groundbreaking medical research! ... Your donation powers the future of medicine and helps save lives. Help Fund Research.

  3. Publications - Matej Markota, M.D. - Mayo Clinic

    Bye KN, Leloux MR, Cole KC, Markota M, Allen ND, Jannetto PJ, Leung JG. Improving result turnaround time as a crucial factor to increasing clozapine ...

  4. Patient Stories - Jeffrey W. Britton, M.D. - Mayo Clinic

    Fuel groundbreaking medical research! ... Your donation powers the future of medicine and helps save lives. Give Today.

  5. Patient Stories - Heidi M. Connolly, M.D. - Mayo Clinic

    Join the fight against cancer! ... Make a gift to our 2025 Drive to Cure Cancer and transform the way cancer is treated and defeated. Give Now.

  6. Publications - Kevin Koo, M.D., M.P.H. - Mayo Clinic

    Rafetto AN, Granberg CF, Koo K. Is Signaling the Solution? Curbing Excess Volumes and Costs of Urology Residency Applications With Large-Volume Preference ...

  7. Outcomes After Secondary Cytoreductive Surgery With or Without Carboplatin Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Followed by Systemic Combination Chemotherapy for Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer - Mayo Clinic

    The drug used for HIPEC will be carboplatin, a Food and Drug Administration (FDA) approved drug for use in ovarian, fallopian tube or primary peritoneal cancer.

  8. Consumer Health: Flu vaccination and cancer - Mayo Clinic News Network

    Having cancer, being treated for cancer or being a cancer survivor increase your risk for flu complications.

  9. Detergents in the Pathogenesis of Eosinophilic Esophagitis - Mayo Clinic

    The purpose of this study is to test the hypothesis that detergents induce mucosal barrier impairment and initiate allergic inflammation in the esophagus.

  10. Patient Stories - Ian R. McPhail, M.D. - Mayo Clinic

    Search for a doctor. Ian R. McPhail, M.D.. Cardiologist; Vascular Medicine Specialist. Request an Appointment · Overview. Patient Stories.